Edgewise Therapeutics, Inc. (EWTX)
40.49
+0.96
(+2.43%)
USD |
NASDAQ |
Oct 28, 16:00
40.45
-0.04
(-0.10%)
After-Hours: 20:00
Edgewise Therapeutics Market Cap : 4.364B for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 4.364B |
| October 27, 2026 | 4.260B |
| October 26, 2026 | 4.222B |
| October 23, 2026 | 4.237B |
| October 22, 2026 | 4.310B |
| October 21, 2026 | 4.273B |
| October 20, 2026 | 4.284B |
| October 19, 2026 | 4.087B |
| October 16, 2026 | 4.008B |
| October 15, 2026 | 4.117B |
| October 14, 2026 | 3.990B |
| October 13, 2026 | 3.910B |
| October 12, 2026 | 4.144B |
| October 09, 2026 | 4.210B |
| October 08, 2026 | 4.228B |
| October 07, 2026 | 4.265B |
| October 06, 2026 | 4.313B |
| October 05, 2026 | 4.343B |
| October 02, 2026 | 4.462B |
| October 01, 2026 | 4.363B |
| September 30, 2026 | 4.376B |
| September 29, 2026 | 4.224B |
| September 28, 2026 | 4.288B |
| September 25, 2026 | 4.240B |
| September 24, 2026 | 4.436B |
| Date | Value |
|---|---|
| September 23, 2026 | 4.424B |
| September 22, 2026 | 4.797B |
| September 21, 2026 | 4.811B |
| September 18, 2026 | 4.884B |
| September 17, 2026 | 5.059B |
| September 16, 2026 | 4.897B |
| September 15, 2026 | 4.702B |
| September 14, 2026 | 4.809B |
| September 11, 2026 | 4.785B |
| September 10, 2026 | 4.624B |
| September 09, 2026 | 4.676B |
| September 08, 2026 | 4.723B |
| September 04, 2026 | 4.642B |
| September 03, 2026 | 4.521B |
| September 02, 2026 | 4.524B |
| September 01, 2026 | 4.554B |
| August 31, 2026 | 4.502B |
| August 28, 2026 | 4.609B |
| August 27, 2026 | 4.763B |
| August 26, 2026 | 4.783B |
| August 25, 2026 | 4.765B |
| August 24, 2026 | 4.820B |
| August 21, 2026 | 4.762B |
| August 20, 2026 | 4.666B |
| August 19, 2026 | 5.005B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cocrystal Pharma, Inc. | 13.65M |
| CNBX Pharmaceuticals, Inc. | 0.1476M |
| Arvinas, Inc. | 496.28M |
| Fulcrum Therapeutics, Inc. | 286.07M |
| Definium Therapeutics, Inc. | 5.119B |
Market Cap Related Metrics
| PEG Ratio | -1.160 |
| Price to Book Value | 9.739 |
| Price | 40.49 |
| Earnings Yield | -4.57% |
| PEGY Ratio | -1.160 |